Fig. 2.
Box and whisker plot demonstrating the distribution of CRP level in patients treated with Tocilizumab and patients treated with TNF-i, JAK-i and other anti-inflammatory medications.
Official websites use .gov
A
.gov website belongs to an official
government organization in the United States.
Secure .gov websites use HTTPS
A lock (
) or https:// means you've safely
connected to the .gov website. Share sensitive
information only on official, secure websites.